Skip to main content

Table 1 Demographic and clinical characteristics of the study’s patients

From: Serum S100B is related to insulin resistance and zinc-α2-glycoprotein levels in patients with chronic schizophrenia

Characteristics

 

n

42

Age (years)

41.60 ± 8.64

Duration of illness (year)

5.50 (3.00,10.50)

Current smokers

29 (69%)

AAPM

13 (30%)

TAPM

20 (47.61%)

CAPM

11 (26.20%)

Body weight (kg)

72.21 ± 12.88

WC (cm)

87.55 ± 9.06

BMI (kg/m2)

24.56 ± 3.92

Obesity

20 (47.60%)

TG (mg/dL)

158.71 ± 52.46

CHOL (mg/dL)

156.05 ± 24.04

HDL-c (mg/dL)

35.46 ± 5.02

LDL-c (mg/dL)

93.07 ± 15.37

Dyslipidemia

27 (64%)

HOMA-IR

1.80 (1.00,3.65)

FBG (mg/dl)

92.33 ± 8.92

HOMA-IR

1.80 (1.00,3.65)

Diabetes

3 (7%)

ZAG (ng/mL)

50.50 (31.15,75.20)

SBP (mmHg)

121.29 ± 8.01

DBP (mmHg)

77.61 ± 2.20

Hypertension

6 (14%)

PANSS-NSS

29.29 ± 4.80

PANSS-PSS

25.76 ± 4.91

PANSS-GPSS

58.07 ± 5.65

PANSS-TS

113.60 ± 11.53

  1. Data are presented as mean ± SD, n (%) or median [percentile 25, 75]
  2. AAPM atypical antipsychotic medications, TAPM typical antipsychotic medications, CAPM combined antipsychotic medications, WC waist circumference, BMI body mass index, TG triglyceride, CHOL cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FBG fasting blood glucose, HOMA-IR homeostatic model assessment—insulin resistance, ZAG zinc alpha 2-glycoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, PANSS Positive and Negative Syndrome Scale, PANSS-NSS PANSS negative subscale score, PANSS-PSS PANSS positive subscale score, PANSS-GPSS PANSS general psychopathology subscale score, PANSS-TS PANSS total score